Sanofi (SNY) R&D US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, € | 5 692 000 000 | 5 692 000 000 | 6 706 000 000 | 6 706 000 000 | 6 725 000 000 | 8 547 000 000 | |||
Changes by years, y/y, % | +3% | 0% | +18% | 0% | +0% | +2.7% |
Sanofi. R&D, €
Sanofi. R&D, changes, %
Sanofi. R&D, sum by quarters, €
Sanofi (SNY) R&D US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D, € | 1 630 000 000 | 1 630 000 000 | 1 663 000 000 | 3 535 000 000 | 1 719 000 000 | 8 547 000 000 | ||
Changes by years, y/y, % | -2% | -2% | -4% | +94% | +10% | |||
Changes by quarters, q/q, % | +4% | 0% | +2% | +113% | -51% |